Manhattan Scientifics Inc (MHTX) financial statements (2022 and earlier)

Company profile

Business Address 244 FIFTH AVENUE
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
SIC 369 - Miscellaneous Electrical Machinery, Equipment, and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 353261872691,0685,364
Cash and cash equivalents 353261872691,0685,364
Receivables 300300  44 
Prepaid expense 1213119  
Total current assets: 665574982781,1125,364
Noncurrent Assets
Property, plant and equipment 64    
Long-term investments and receivables   1,3545,5052 
Long-term investments   1,3545,5052 
Intangible assets, net (including goodwill)    23630793
Intangible assets, net (excluding goodwill)    23630793
Regulated entity, other noncurrent assets     688884
Other noncurrent assets   2224
Other undisclosed noncurrent assets 6,1771,6471,2065,0385,2015,824
Total noncurrent assets: 6,1831,6512,56210,5686,5237,505
TOTAL ASSETS: 6,8482,2252,66010,8467,63512,869
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 8531,8602212091,335829
Accrued liabilities 8531,860    
Interest and dividends payable      290
Other undisclosed accounts payable and accrued liabilities   2212091,335539
Debt 150     
Due to related parties   1,5311,41810510
Other undisclosed current liabilities 9234  274450
Total current liabilities: 1,0122,0941,7521,6271,7141,289
Noncurrent Liabilities
Long-term debt and lease obligation     2,1391,928
Long-term debt, excluding current maturities     2,1391,928
Other undisclosed noncurrent liabilities 10478    
Total noncurrent liabilities: 10478  2,1391,928
Other undisclosed liabilities     154
Total liabilities: 1,1162,1721,7521,6273,8543,271
Temporary equity, carrying amount   1,0581,0581,0581,058
Stockholders' equity
Stockholders' equity attributable to parent, including: 4,674(1,028)(150)8,1612,7238,594
Common stock 559558534534  
Treasury stock, value      (330)
Additional paid in capital 68,99667,63267,28967,28963,52763,617
Accumulated deficit (64,881)(69,195)(67,973)(59,662)(61,338)(55,230)
Other undisclosed stockholders' equity attributable to parent  (23)  534537
Other undisclosed stockholders' equity 1,05823   (54)
Total stockholders' equity: 5,732(1,005)(150)8,1612,7238,540
Other undisclosed liabilities and equity  1,058    
TOTAL LIABILITIES AND EQUITY: 6,8482,2252,66010,8467,63512,869

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 5097 14215030
Revenue, net 15064
Cost of revenue
(Cost of Goods and Services Sold)
    (189)  
Gross profit: 5097 (47)15030
Operating expenses (725)(1,122)(1,448)(2,420)(6,533)(6,315)
Other undisclosed operating income    189 34
Operating loss: (675)(1,025)(1,448)(2,278)(6,383)(6,251)
Nonoperating income (expense) 4,989(197) 7,940  
Investment income, nonoperating  (192) 7,940  
Interest and debt expense (25)5  275(675)
Income (loss) from continuing operations before income taxes: 4,289(1,217)(1,448)5,662(6,108)(6,926)
Other undisclosed income from continuing operations      14,938
Income (loss) before gain (loss) on sale of properties: 4,289(1,217)(1,448)5,662(6,108)8,012
Other undisclosed net loss  (5)    
Net income (loss): 4,289(1,222)(1,448)5,662(6,108)8,012
Other undisclosed net income (loss) attributable to parent 25 (6,886)(4,116)  
Net income (loss) available to common stockholders, diluted: 4,314(1,222)(8,334)1,546(6,108)8,012

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): 4,289(1,222)(1,448)5,662(6,108)8,012
Comprehensive income (loss), net of tax, attributable to parent: 4,289(1,222)(1,448)5,662(6,108)8,012

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: